Advertisement

Tumor Biology

, Volume 34, Issue 2, pp 1225–1233 | Cite as

Lack of association between MHTFR Glu429Ala polymorphism and breast cancer susceptibility: a systematic review and meta-analysis of 29 research studies

  • Zhanjiang Jiao
  • Dan Li
Research Article

Abstract

The association between MHTFR Glu429Val polymorphism and breast cancer risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. A total of 29 studies including 8,649 cases and 18,672 controls were involved in this meta-analysis. Overall, no significant associations were found between MTHFR Glu429Ala polymorphism and breast cancer risk when all studies were pooled into the meta-analysis (Glu/Glu vs Ala/Ala: OR = 0.891, 95 % CI = 0.782–1.015; Glu/Ala vs Ala/Ala: OR = 0.874, 95 % CI = 0.760–1.006; dominant model: OR = 0.885, 95 % CI = 0.775–1.012; and recessive model: OR = 0.989, 95 % CI = 0.931–1.051). In the subgroup analysis by ethnicity, significantly elevated breast cancer risk was associated with Glu/Glu variant genotype in homozygote comparison and recessive genetic model (Glu/Glu vs Ala/Ala: OR = 0.78, 95 % CI = 0.63–0.97; Glu/Glu vs Glu/Ala: OR = 0.92, 95 % CI = 0.85–0.99; recessive model: OR = 0.91, 95 % CI = 0.85–0.97), while no significant associations were found for all comparison models in other ethnicity populations. In conclusion, this meta-analysis suggests that the MTHFR Glu429Ala polymorphism may be not associated with breast cancer development.

Keywords

Polymorphism Breast cancer MTFHR Susceptibility Meta-analysis 

Notes

Conflicts of interest

None

References

  1. 1.
    Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology. The lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004;6:213–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Dumitrescu RG, Cotarla I. Understanding breast cancer risk—where do we stand in 2005. J Cell Mol Med. 2005;9:208–21.PubMedCrossRefGoogle Scholar
  3. 3.
    Put NM. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects. Am J Hum Genet. 1998;62:1044–51.PubMedCrossRefGoogle Scholar
  4. 4.
    Sharp L, Little J, Schofield AC, Pavlidou E, Cotton SC, Miedzybrodzka Z, et al. Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett. 2002;181:65–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Ergul E, Sazci A, Utkan Z, Canturk NZ. Polymorphisms in the MTHFR gene are associated with breast cancer. Tumour Biol. 2003;24:286–90.PubMedCrossRefGoogle Scholar
  6. 6.
    Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hebert JR, et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev. 2004;13:190–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Försti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep. 2004;11:917–22.PubMedGoogle Scholar
  8. 8.
    Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Hen-derson BE. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2004;13:2071–7.PubMedGoogle Scholar
  9. 9.
    Qi J, Miao XP, Tan W, Yu CY, Liang G, Lu WF, et al. Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of breast cancer. Chin J Oncol. 2004;26:287–9.Google Scholar
  10. 10.
    Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res. 2005;65:1606–14.PubMedCrossRefGoogle Scholar
  11. 11.
    Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, et al. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels, and breast cancer susceptibility: a case–control study in Taiwan. Carcinogenesis. 2006;27:2295–300.PubMedCrossRefGoogle Scholar
  12. 12.
    Kalyankumar C, Jamil K. Methylene tetrahydofolate reductase (MTHFR) C677T and A1298C polymorphisms and breast cancer in South Indian population. Int J Cancer Res. 2006;2:143–51.CrossRefGoogle Scholar
  13. 13.
    Xu X, Gammon MD, Zhang H, Wetmur JG, Rao M, Teitelbaum SL, et al. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis. 2007;28:1504–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, Welch R. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case–control study and meta-analyses. Int J Cancer. 2007;120:2696–703.PubMedCrossRefGoogle Scholar
  15. 15.
    Kan XX, Zou TN, Wu XY, Wang X. Association between mTHFR genotype polymorphism and breast cancer susceptibility in human population from Yunnan. Cancer Res Prev Treat. 2007;34:716–8.Google Scholar
  16. 16.
    Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, Thun MJ, et al. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2007;16:1140–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Inoue M, Robien K, Wang R, Van Den Berg DJ, Koh WP, Yu MC. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis. 2008;29:1967–72.PubMedCrossRefGoogle Scholar
  18. 18.
    Kotsopoulos J, Zhang WW, Zhang S, McCready D, Trudeau M, Zhang P, et al. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat. 2008;112:585–93.PubMedCrossRefGoogle Scholar
  19. 19.
    Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, Wang HW, et al. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res Treat. 2008;111:145–55.PubMedCrossRefGoogle Scholar
  20. 20.
    Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H, et al. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev. 2009;18:1101–10.PubMedCrossRefGoogle Scholar
  21. 21.
    Gao CM, Tang JH, Cao HX, Ding JH, Wu JZ, Wang J, et al. MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women. J Hum Genet. 2009;54:414–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Ma E, Iwasaki M, Kobayashi M, Kasuga Y, Yokoyama S, Onuma H, et al. Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case–control study in Japan. Nutr Cancer. 2009;61:447–56.PubMedCrossRefGoogle Scholar
  23. 23.
    Platek ME, Shields PG, Marian C, McCann SE, Bonner MR, Nie J, et al. Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18:2453–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Ma E, Iwasaki M, Junko I, Hamada GS, Nishimoto IN, Carvalho SM, et al. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case–control study in Brazilian women. BMC Cancer. 2009;9:122.PubMedCrossRefGoogle Scholar
  25. 25.
    Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Khuhaprema T, Yoshida T. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women. Breast Cancer Res Treat. 2010;123:885–93.PubMedCrossRefGoogle Scholar
  26. 26.
    Weiner AS, Boyarskih UA, Voronina EN, Selezneva IA, Sinkina TV, Lazarev AF, et al. Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR and C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in the West Siberian Region of Russia. Mol Biol. 2010;44(5):720–7.CrossRefGoogle Scholar
  27. 27.
    Hosseini M, Houshmand M, Ebrahimi A. MTHFR polymorphisms and breast cancer risk. Arch Med Sci. 2011;7(1):134–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Cerne JZ, STeGel V, GerSaK K, Novakovic S. Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk. Mol Med Rep. 2011;4:175–9.Google Scholar
  29. 29.
    Akram M, Malik FA, Kayani MA. Mutational analysis of the MTHFR gene in breast cancer patients of Pakistani population. Asian Pac J Cancer Pre. 2012;13:1599–603.CrossRefGoogle Scholar
  30. 30.
    Papandreou CN, Doxani C, Zdoukopoulos N, Vlachostergios PJ, Hatzidaki E, Bakalos G, et al. Evidence of association between methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a candidate-gene association study in a South-eastern European population. DNA Cell Biol. 2012;31(2):193–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Carvalho Barbosa RC, Menezes DC, Freire TFV, Sales DC, Alencar VHM, Rabenhorst SHB. Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent. Mol Biol Rep. 2012;39:4899–907.CrossRefGoogle Scholar
  32. 32.
    Lajin B, Alhaj Sakur A, Ghabreau L, Alachkar A. Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women. Tumor Biol. 2012;33:1133–9.CrossRefGoogle Scholar
  33. 33.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  34. 34.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  35. 35.
    Fujisawa T, Ikegami H, Kawaguchi Y, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia. 1998;41(1):47–53.PubMedCrossRefGoogle Scholar
  36. 36.
    Liwei L, Chunyu L, Ruifa H. Association between manganese superoxide dismutase gene polymorphism and risk of prostate cancer: a meta-analysis. Urology. 2009;74(4):884–8.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of Hepatobiliary Surgery, Nanfang HospitalSouthern Medical UniversityGuangzhouChina
  2. 2.Hubei Provincial Corps HospitalChinese People’s Armed Police ForcesWuhanChina

Personalised recommendations